Physician profile
Ashley Moss
NPI 1043541287
$3,446.45
in general payments reported to CMS, 2019-2025
17 companies · $997 in 2025
The $997 reported for 2025 was more than what 96% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $493 · 2022: $549 · 2023: $708 · 2024: $699 · 2025: $997.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,205 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,205.49 |
| Education | $198.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $943.20 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $622.11 | 2022-2025 | |
| Abbvie INC. | $495.73 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $305.68 | 2021-2025 | |
| Exeltis, USA INC. | $209.10 | 2021-2025 | Slynd |
| Biogen, INC. | $190.23 | 2025 | Zurzuvae |
| Millicent US INC | $136.12 | 2022-2025 | Intrarosa, Femlyv |
| Organon LLC | $106.22 | 2021-2024 | |
| Agile Therapeutics, INC. | $105.45 | 2021-2022 | |
| Exact Sciences Corporation | $98.67 | 2023-2024 | Cologuard Collection Kit |
| Channel Medsystems, INC. | $73.76 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $41.69 | 2025 | Myfembree |
| Hologic Sales and Service, LLC | $37.77 | 2023-2025 | Myosure Tissue Removal Device, Omni Hysteroscope |
| Coopersurgical, INC. | $34.17 | 2021-2024 | Paragard T 380a |
| Amgen INC. | $18.89 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $14.39 | 2022 | |
| Mylan Pharmaceuticals INC. | $13.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Moss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.